Michael Dosch pSC autoimmunity in human T1D. a, Proliferative T-cell responses to GFAP (green) and S100ß (yellow) in peripheral blood mononuclear cells from newly diabetic children, ICA ...

Type 1 diabetes (T1D) is an autoimmune condition characterized by the destruction of insulin-producing beta cells in the pancreas, leading to high blood sugar levels. Research in this area has ...

A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of insulin-producing islet beta cells taken from deceased donors. The Chicago-based ...

Type 1 diabetes is an immune-mediated disease ... T cells in a sea of nonspecific bystanders can drive complete beta-cell destruction 15, the question of whether there is a particular TCR that ...

While its exact cause is not clear, Type 1 diabetes is believed to be impacted by an autoimmune reaction, states the CDC. This leads to the destruction of beta cells. If you have Type 1 diabetes ...

MHH team aims to intervene in the autoimmune process and stop the destruction of insulin-producing beta cells in the pancreas ...

according to a doctor Type 1 diabetes is an autoimmune disease where beta cells, a hormone located in the pancreas that creates insulin, are destroyed, Busui says. This destruction may happen ...

Sana Biotechnology’s hypoimmune platform enables it to make a series of genetic modifications to cells, rendering the cells invisible to a patient’s immune system.

(Beta cell destruction leads to type 1 diabetes). The squiggly "tail" on the T cells, which switches from blue to red to yellow, is a tracking mechanism inserted by the researchers to record the T ...

Autoantibodies against GFAP may represent a new and early serum marker of high diabetes ... (1:150), 3.5, 5, 6, 8, 10 and 20 weeks old, respectively; lane 8, 1:1,000 IgG GFAP antibody. B-and T ...